About this document
Hepatitis C Editorial by Luis Adolfo Bermudez is a document available to read on EtoBox.
A new era of therapy for hepatitis C virus is dawning with the development of two effective HCV protease inhibitors. Boceprevir, in combination with peginterferon and ribavirin, does not have clinically significant activity against other genotypes. The presence of cirrhosis has a negative impact on response to therapy.
- Author
- Luis Adolfo Bermudez
- Language
- EN